Trial of Divalproex for Bipolar Disorder

The safety and effectiveness of divalproex sodium (Depakapote®) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: J Gordon Millichap (VerfasserIn)
Format: Buch
Veröffentlicht: Pediatric Neurology Briefs Publishers, 2002-10-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

Connect to this object online.

3rd Floor Main Library

Bestandsangaben von 3rd Floor Main Library
Signatur: A1234.567
Exemplar 1 Verfügbar